In a striking move that could reshape global trade dynamics, EU member states are backing a proposal to restrict the participation of Chinese suppliers in public procurement, specifically in the medical devices sector. 🔍
The proposed measures would mark the first use of the EU International Procurement Instrument (IPI), limiting third country bidders from competing for lucrative public contracts in the EU. This shift could mean tougher challenges for Chinese companies trying to win public tenders.
The China Chamber of Commerce to the EU (CCCEU) has voiced concerns, arguing that the decision adds layers of complexity to China-EU economic and trade relations. They claim it contradicts the EU's own principles of openness, fairness, and non-discrimination in market access. 🤔
On the other hand, China's Ministry of Commerce has strongly opposed the measure, describing it as a protectionist move that may raise additional barriers in trade between the EU and the Chinese mainland.
This development unfolds against the backdrop of the World Trade Organization's Government Procurement Agreement (GPA), which mandates equal treatment for all bidders. Traditionally, the competitive offers from Chinese suppliers have seen them secure numerous public contracts in the EU. Now, the new restrictions signal a notable shift in how public procurement is approached.
As global trade rules continue to evolve, all eyes are on how these restrictions might influence competition and market access in the public procurement arena. Stay tuned as we follow this evolving story and explore what it means for the future of international commerce. 🌏✨
Reference(s):
New restrictions for Chinese companies in EU public procurement
cgtn.com
